Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Acq. announced
Appointed CFO
Quarterly results
|
|
Precipio, Inc. (PRPO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/06/2023 |
8-K
| Other Events Interactive Data |
| 08/14/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 06/15/2023 |
8-K
| Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits Interactive Data |
| 06/12/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...|
Docs:
|
"590 Madison Avenue, 28 th Floor, 10022, 212-624-2060 Member FINRA, SIPC 1 6. Amendment . No amendment to this Agreement shall be valid unless such amendment is in writing and is signed by authorized representatives of all the parties to this Agreement. 7. Waiver . Any of the terms and conditions of this Agreement may be waived at any time and from time to time in writing by the party entitled to the benefit thereof, but a waiver in one instance shall not be deemed to constitute a waiver in any other instance. A failure to enforce any provision of this Agreement shall not operate as a waiver of this provision or of any other provision hereof. 8. Severability . In the event that any provision of this Agreement shall be held to be invalid, illegal, or unenforceable in any circumstances, the r...",
"Pre-Funded WARRANT To purchase Shares of Common Stock PRECIPIO, INC. Warrant Shares: ___________ Initial Exercise Date: June 12, 2023 THIS Pre-Funded WARRANT to Purchase Shares of Common Stock certifies that, for value received, _____________ or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof until this Warrant is exercised in full , but not thereafter, to subscribe for and purchase from Precipio, Inc., a Delaware corporation , up to ______ shares of common stock, par value $0.01 per share . The purchase price of one Warrant Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2. Section 1 . Definitions . Capitalized terms used and not otherwi...",
"WARRANT TO PURCHASE SHARES OF COMMON STOCK PRECIPIO, INC. Warrant Shares: [ ] Issue Date: June 12, 2023 THIS WARRANT TO PURCHASE SHARES OF COMMON STOCK certifies that, for value received, [_______] or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after December 12, 2023 and on or prior to 5:00 p.m. on December 12, 2028 , but not thereafter, to subscribe for and purchase from Precipio, Inc., a Delaware corporation , up to [ ] shares of common stock, par value $0.01 per share . The purchase price of one Warrant Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2. Section 1 . Definitions . Capitalized terms used and not otherwise defined herein shall have the mea...",
"100 Northern Avenue Boston, MA 02210",
"SECURITIES PURCHASE AGREEMENT",
"LOCK-UP AGREEMENT June [__], 2023 A.G.P./Alliance Global Partners 590 Madison Avenue New York, New York 10022 Re: Precipio, Inc.—Proposed Offering of Securities",
"DELIVERY OF FINAL LETTER IS SUBJECT TO COMPLETION OF GOODWIN PROCTER LLP’ S OPINION REVIEW AND CLEARANCE PROCEDURES",
"Precipio, Inc. Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement NEW HAVEN, CT, - Specialty cancer diagnostics company Precipio, Inc. , today announced it has entered into securities purchase agreements with certain institutional investors for the purchase and sale of 4,125,000 shares of the Company’ s common stock and pre-funded warrants to purchase 319,445 shares of the Company’ s common stock in a registered direct offering and warrants to purchase up to 8,888,890 shares of common stock at a combined purchase price of $0.45 in a concurrent private placement . The pre-funded warrants will have a nominal exercise price of $0.001 per share and will be immediately exercisable and of indefinite term. The common warrants issued pursuant to the concurr..." |
|
| 04/27/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and... |
| 03/29/2023 |
8-K
| Quarterly results |
| 11/21/2022 |
8-K
| Quarterly results |
| 11/03/2022 |
8-K
| Quarterly results |
| 10/31/2022 |
8-K
| Quarterly results |
| 09/19/2022 |
8-K
| Other Events Interactive Data |
| 09/19/2022 |
8-K
| Other Events Interactive Data |
| 08/08/2022 |
8-K
| Quarterly results |
| 07/20/2022 |
8-K
| Quarterly results |
| 07/05/2022 |
8-K
| Quarterly results |
| 06/15/2022 |
8-K
| Quarterly results |
| 06/13/2022 |
8-K
| Quarterly results |
| 03/21/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 02/25/2022 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 08/20/2021 |
8-K
| Quarterly results |
| 08/12/2021 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 07/28/2021 |
8-K
| Quarterly results |
| 06/21/2021 |
8-K
| Quarterly results |
| 06/15/2021 |
8-K
| Quarterly results |
| 06/15/2021 |
8-K
| Quarterly results |
| 05/17/2021 |
8-K
| Quarterly results |
| 04/02/2021 |
8-K
| Quarterly results |
| 03/18/2021 |
8-K
| Quarterly results |
| 03/03/2021 |
8-K
| Quarterly results |
| 11/12/2020 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 09/04/2020 |
8-K
| Quarterly results |
| 08/28/2020 |
8-K
| Quarterly results |
| 08/07/2020 |
8-K
| Quarterly results |
| 07/22/2020 |
8-K
| Quarterly results |
| 07/13/2020 |
8-K
| Quarterly results |
|
|
|